Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2018-04-18 Management Reports
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
2017年度独立董事述职报告（温泉）
Management Reports Classification · 95% confidence The document is titled as the "2017年度独立董事述职报告" which translates to "2017 Annual Independent Director's Work Report." It details the independent director's activities, attendance at board and shareholder meetings, opinions on various company matters including financial reports, audit reports, internal controls, related party transactions, and other governance issues for the year 2017. The content is a detailed management report from an independent director about their oversight and opinions on company governance and financial matters during the year. It is not a full annual report (10-K), audit report (AR), or earnings release (ER), but rather a management report focusing on governance and oversight activities. This fits best under the category of Management Reports (MDA), which includes management's detailed explanation of financial results, business trends, and outlook, as well as governance oversight by directors. The document is substantive and over 10,000 characters, so it is not a mere announcement or certification. Therefore, the classification is MDA with high confidence.
2018-04-18 Chinese
2017年年度报告摘要
Annual Report Classification · 100% confidence The document is titled "西藏易明西雅医药科技股份有限公司 2017 年年度报告摘要" which translates to "Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd. 2017 Annual Report Summary." It contains detailed financial data for the year 2017, including revenue, net profit, earnings per share, and other financial metrics. It also discusses business operations, product lines, accounting policy changes, and shareholder information. The document is over 12,000 characters long, indicating it is a substantive report rather than a brief announcement. The content aligns with an official yearly report covering company activity and full financial performance, which fits the definition of an Annual Report (10-K). There is no indication that this is merely an announcement or a certification, so it is not classified as RPA or RNS. Therefore, the correct classification is Annual Report (10-K). FY 2017
2018-04-18 Chinese
华西证券股份有限公司关于公司的定期现场检查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "定期现场检查报告" which translates to "Periodic On-site Inspection Report" by a sponsoring securities company regarding a listed company. The content focuses on governance, internal control, information disclosure, use of raised funds, and performance checks. It is a detailed compliance and inspection report rather than a financial statement or earnings release. It does not contain financial statements or quarterly/yearly financial results. It is not an announcement of voting results, management changes, or capital changes. It is a regulatory compliance inspection report related to governance and internal controls. This fits best under the category of Audit Report / Information (AR), which includes internal or regulatory stress tests and audit-related reports excluding full annual reports. The document length is under 5,000 characters but contains substantive inspection content, so it is not a mere announcement. Therefore, the classification is AR with high confidence. FY 2018
2018-04-18 Chinese
华西证券股份有限公司关于公司2017年内部控制自我评价报告和内部控制规则落实自查表核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an internal control self-evaluation report and internal control rules implementation checklist for the year 2017, issued by Huaxi Securities as the sponsor institution for Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd. It contains detailed descriptions of the internal control environment, implementation, and compliance with relevant laws and regulations. The document includes specific financial data related to the use and management of raised funds, internal control procedures, and a formal verification opinion by the sponsor. The document is about internal control evaluation and audit-related opinions but is not a full annual report or audit report by an external auditor. It is a standalone audit-related verification report on internal controls, which fits the definition of an Audit Report / Information (AR). The document length is 3852 characters, which is sufficient to contain substantive content rather than just an announcement. Therefore, the classification is AR with high confidence. FY 2017
2018-04-18 Chinese
2017年财务决算报告
Annual Report Classification · 100% confidence The document is titled "2017 年财务决算报告" which translates to "2017 Financial Final Accounts Report". It contains detailed financial statements including balance sheets, profit and loss statements, cash flow statements, and extensive financial analysis for the fiscal year 2017. The document includes audited financial data with an unqualified audit opinion from an accounting firm, detailed financial metrics, and comprehensive management discussion of financial results and business conditions. The length of the document (over 13,000 characters) and the presence of full financial statements and analysis indicate this is a full annual financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K equivalent). FY 2017
2018-04-18 Chinese
募集资金年度存放与使用情况鉴证报告（2017年度）
Regulatory Filings
2018-04-18 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.